The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks to provide long term capital growth.
The fund has a non-fundamental policy to invest, under normal circumstances, at least 80% of the value of its net assets plus borrowings for investment purposes in equity securities. It invests principally in equity securities, including common stocks issued by companies economically tied to or located in developed market countries, other than the U.S.
The average market capitalization across the Russell Inv Multifactor Intl Eq Y MF is 185.33B. The market cap for tickers in the group ranges from 3.51M to 381.12B. ASML holds the highest valuation in this group at 381.12B. The lowest valued company is NOVN at 3.51M.
The average weekly volume growth across all stocks in the Russell Inv Multifactor Intl Eq Y MF was -5%. For the same stocks of the MF, the average monthly volume growth was -10% and the average quarterly volume growth was 32%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 40
P/E Growth Rating: 40
Price Growth Rating: 56
SMR Rating: 64
Profit Risk Rating: 42
Seasonality Score: 24 (-100 ... +100)